CeQur
PrivateLast Round
Series E
Jun 9, 2026
Total Funding Raised
$514M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CeQur is a medical device company that develops and commercializes wearable insulin delivery patches designed to simplify mealtime insulin administration for patients with diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CeQur Comparables
Compare CeQur with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MannKind Corp | 78% | |
| PharmaSens AG | 75% | |
| Tandem Diabetes Care, Inc. | 75% |
For institutional investors. Book with your work email.
CeQur Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jun 9, 2026 | ||||
| Series D | Jan 7, 2025 | ||||
| Series C Extension | Apr 13, 2021 | ||||
| Series C | Sep 1, 2015 | ||||
| Series B | Sep 9, 2013 | ||||
Series A | Jan 5, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CeQur Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GMS Capital | Series C Extension |
| VI Partners | Series C Extension, Series D, Series C, Series A, Series B |
| Schroder Investment Management Limited | Series A |
| Woodford Investment Management | Series C |
| Endeavour Vision | Series D, Series B, Series C, Series A, Series C Extension |
| GMS Capital Partners | Series C Extension |
| Schroder & Co. Bank | Series C Extension, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
$100M round raised.
- Jan 7, 2025
$120M raised in early funding.
For institutional investors. Book with your work email.
CeQur Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CeQur's valuation, stock price, and market status.
Is CeQur a public or private company?
CeQur is a private company.
What is the current stock price of CeQur?
CeQur is a private company, so its shares have no public market price. Caplight tracks CeQur's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CeQur worth (valuation)?
Valuation information for CeQur is not publicly available.
Can I buy CeQur stock?
CeQur shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CeQur's last funding round?
CeQur's most recent funding round was Series E on June 9, 2026.
Who are the main investors in CeQur?
Key investors in CeQur include VI Partners, Woodford Investment Management, Endeavour Vision, Arthurian Life Sciences, Credit Suisse NEXT Investors.
Will CeQur IPO soon?
No public IPO plans have been announced for CeQur.
How can I track CeQur secondary market activity?
Caplight tracks bids, offers, and trades in CeQur's shares on secondary markets.